UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 6 | June 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 5
May-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2405647


Registration ID:
540486

Page Number

g395-g404

Share This Article


Jetir RMS

Title

Mucormycosis: An Emerging Fungal Threat in the 21st Century

Authors

Abstract

Mucormycosis also known as black fungus, is a serious fungal infection but rare type caused by a group of moulds called mucoromycete’s. Mucormycosis is an angio invasive contamination that takes place because of the fungi mucorales. It is a rare disease but increasingly common in immunocompromised patients. It is categorized into rhino-orbito-cerebral, cutaneous, disseminated, gastrointestinal, and pulmonary types. This infection mainly targets diabetic and immunocompromised patients. COVID-19 patients are also affected by these fungi, as it declines the immunity of a patients.Mucormycosis cases are also increasing due to inhalation of molds containing industrial oxygen. The coronavirus disease pandemic of 2019 (COVID-19) is still on the rise. The second wave of this disease has caused alarm in many countries, including India and regions of the world that are experiencing the third wave. Because there are no effective treatment choices or therapies for this lethal virus, supportive care equipment such as oxygen cylinders, ventilators, and high steroid use are essential in the management of COVID-19. COVID-19 individuals are contracting secondary illnesses such as mucormycosis, popularly known as black fungus disease, in the midst of the epidemic. Patients who are immunocompromised due to diabetes mellitus, neutropenia, organ transplantation, and/or elevated serum levels of accessible iron are at risk of contracting the potentially fatal infection known as mucormycosis.There are more individuals at risk for this fatal illness due to the rising rates of organ donation, diabetes mellitus, and cancer. The overall mortality rate is high despite rigorous therapy, which involves frequently supplemental toxic antifungal therapy and disfiguring surgical debridement. Mucormycosis is a potentially fatal illness that can affect patients who are immunocompromised due to diabetes mellitus, neutropenia, organ transplantation, and/or excessive serum levels of accessible iron.A greater number of people are susceptible to this deadly disease as a result of the growing numbers of organ transplants, diabetes, and cancer. Despite intensive care, which often includes further toxic antifungal therapy and disfiguring surgical debridement, the overall mortality rate remains high.

Key Words

Diabetes Mellitus,Rhino cerebral Mucormycosis, Fungal invasion, COVID 19.

Cite This Article

"Mucormycosis: An Emerging Fungal Threat in the 21st Century", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 5, page no.g395-g404, May-2024, Available :http://www.jetir.org/papers/JETIR2405647.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Mucormycosis: An Emerging Fungal Threat in the 21st Century", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 5, page no. ppg395-g404, May-2024, Available at : http://www.jetir.org/papers/JETIR2405647.pdf

Publication Details

Published Paper ID: JETIR2405647
Registration ID: 540486
Published In: Volume 11 | Issue 5 | Year May-2024
DOI (Digital Object Identifier):
Page No: g395-g404
Country: bidrahalli , karnataka, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00022

Print This Page

Current Call For Paper

Jetir RMS